Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 405 results for "zydus group"

STARCH : Indian diabetes population consumes high amounts of c...

Bayer Zydus Pharma, in collaboration with Prof Dr. Shashank Joshi (Padma Shri awardee and President of Association of Physicians of India) and nine other imminent endocrinologists/diabetologists, conducted the STARCH study across five regions in ... India Infoline, 1 week ago
Business Standard India

Zydus Wellness consolidated Sep '14 sales at Rs 103.03 crore

'13 Net Sales/Income from operations 102.76 100.73 97.13 Other Operating Income 0.27 0.18 0.56 Total Income From Operations 103.03 100.91 97.69 EXPENDITURE Consumption of Raw Materials 31.82 28.23 24.07 Purchase of Traded Goods 0.25 0.69 0.88 ...
 Moneycontrol.com3 weeks ago Buy Cadila Healthcare; tgt of Rs 1410: Firstcall Research  Moneycontrol.com1 month ago Zydus and Gilead Enter into a Generic Licensing Agreement to manufacture breakthrough treatment for Hepatitis C  Equity Bulls2 months ago Zydus Cadila bags license for hepatitis C drug  Sify2 months ago
[x]  
India TV

Zydus gets USFDA nod to market anti-diabetic tablets; closes down 1.15%

Cadila Healthcare closed today at 1.15% at Rs. 1,272 on BSE. The stock opened at Rs. 1,300 and closed at Rs. 1,272. The stock hit a high of Rs. 1323 and a low of Rs. 1,262. Zydus Cadila has received tentative approval from the USFDA to market ...
 India Infoline2 months ago Zydus Cadila gets tentative approval from US FDA for Glipizide ER tablets  Indian-Commodity2 months ago Zydus gets USFDA tentative nod for diabetic tablets  Press Trust of India2 months ago Zydus receives tentative approval for Glipizide ER tablets  India Infoline2 months ago
[x]  

Stock Prices as on Oct 16, 2014

GROUP A A A B B 1013.55(1055.7) 1263-540 (7) A C C 1377.85(1383.5) 1570-971 (17) Abbot 3034.9(3058.4) 3462-1305 (1) Abg Shipyard 222.3(233.55) 327-210 (31) Abirlanuv 1593.0(1636.0) 1738-1030 (8) Acl 205.35(208.55) 243-150 (70) Adani Enter 444.2(452.95) ...
 Deccan Herald1 month ago

NPPA price control buzz positive for Sanofi, Zydus, Ranbaxy:Angel Broking

The National Pharmaceutical Pricing Authority (NPPA) has withdrawn guidelines for price control of 108 formulations, which was issued under Para, 19 of the drug prices control order (DPCO). NPPA had capped prices of 108 cardiac and diabetes drugs on ...
 MyIris2 months ago Industry hails move  The Hindu2 months ago

Supernus Files Trokendi XR Patent Infringement Lawsuit - Analyst Blog

Supernus Pharmaceuticals, Inc. ( SUPN ) has filed a patent infringement lawsuit against Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited accusing them of infringement of three patents covering Supernus' antiepileptic drug, Trokendi XR.
 Nasdaq4 days ago Supernus Sues Zydus for Infringement of Trokendi XR(R) Patents  Stockwatch1 week ago Supernus Pharmaceuticals Sues Zydus Pharmaceuticals (USA) Inc. For Infringement Of Trokendi XR(R) Patents  BioSpace4 days ago Supernus Pharmaceuticals : Sues Zydus for Infringement of Trokendi XR(R) Patents  4 Traders1 week ago
[x]  

Dr. Datsons Labs to receive Transformational & Come Back Company of the year at Pharmaleaders

Dr. Datsons Labs to receive Transformational & Come Back Company of the year for sustained healthcare innovations Dr. Datsons Labs bounces back with transformation in healthcare excellence, voted as Transformational & Come Back Company of the year ...
 PharmiWeb1 day ago Shahnaz Husain, Pankaj Patel,Dr V Mohan,Dr Somaraju,Dilip Surana, among others to receive Pharmaleaders 2014 Awards  IndiaPRwire4 days ago

Type 2 Diabetes - Pipeline Review, H2 2014 - New Study Released

Global Markets Direct's, 'Type 2 Diabetes - Pipeline Review, H2 2014', provides an overview of the Type 2 Diabetes's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Type 2 Diabetes, complete ...
 CEOWorld Magazine2 days ago
[x]  

MCI summons 300 doctors for promoting costly brands of Ahmedabad based drug co

The Medical Council of India (MCI) is in the process of scrutinising a complaint revealing names of 300 doctors for illegally promoting the products of an Ahmedabad based pharma company. According to the complaint, pharma company's brand which are ...
 PharmaBiz1 week ago
Times of India

Pharmaceutical Newsletter - November 17 to 21, 2014

Top News Aurobindo Pharma's director Reddy shot at Hyderabad's Banjara Hills Aurobindo Pharma's director K Nityananda Reddy was shot at by an unidentified man carrying an AK-47 rifle, according to reports. At Jubilee Hills around 7 am, Reddy got ...
 India Infoline1 week ago US investigates Dr Reddy's and Sun Pharma over generic drugs price increases  Pharmaceutical Business Review1 month ago DrReddy's, Sun Pharma among 14 cos probed by US Cong over drug price  The Freepress Journal1 month ago DRL, Sun Pharma among 14 companies facing price probe in US  Times of India1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less